Calcium citrate and Para drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Calcium citrate (calcium) and Para (para - aminobenzoic acid (paba)). Common drug interactions include abdominal discomfort among females.

The phase IV clinical study analyzes what interactions people have when they take Calcium citrate and Para. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Calcium citrate?

Calcium citrate has active ingredients of calcium. It is often used in osteopenia. eHealthMe is studying from 12,606 Calcium citrate users. Check the latest studies of Calcium citrate.

What is Para?

Para has active ingredients of para - aminobenzoic acid (paba). eHealthMe is studying from 2,194 Para users. Check the latest studies of Para.



On Jul, 20, 2026

26 people who take Calcium citrate and Para together, and have interactions are studied.

Calcium citrate and Para drug interactions.

What are the common drug interactions of Calcium Citrate and Para, by gender? *:

female:

  1. Abdominal discomfort
  2. Adjustment disorder with depressed mood
  3. Depression
  4. Diarrhoea
  5. Discomfort
  6. Dislocation of vertebra
  7. Dizziness
  8. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
  9. Duodenal ulcer perforation (untreated ulcer can burn through the wall of the stomach)
  10. Dyspepsia (indigestion)

male:

n/a

What are the common drug interactions of Calcium Citrate and Para, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  2. Pyrexia (fever)

60+:

  1. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  2. Peripheral swelling

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 3 people, 11.54%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 7.69%
  3. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 7.69%
  4. Psoriasis (immune-mediated disease that affects the skin): 2 people, 7.69%
  5. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Calcium citrate and Para?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Calcium citrate and Para:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Calcium citrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Para:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Calcium citrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Para and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on calcium and para - aminobenzoic acid (paba) (the active ingredients of Calcium citrate and Para, respectively), and Calcium citrate and Para (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: